Rezultati - Edward R. Scheffer Cliff

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma

    Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma od Edward R. Scheffer Cliff, Gemma Reynolds, Rakesh Popat, Benjamin W. Teh, Aaron S. Kesselheim, Ghulam Rehman Mohyuddin

    Izdano 2023
    Polni tekst Polni tekst
    Carta
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions

    High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions od Edward R. Scheffer Cliff, Amar H. Kelkar, David A. Russler‐Germain, Frazer A. Tessema, Adam Raymakers, William B. Feldman, Aaron S. Kesselheim

    Izdano 2023
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis

    Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis od Gemma Reynolds, Marsali Maclean, Edward R. Scheffer Cliff, Benjamin W. Teh, Karin Thursky, Monica A. Slavin, Mary Ann Anderson, Eliza A. Hawkes

    Izdano 2024
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis

    Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis od Gemma Reynolds, Edward R. Scheffer Cliff, Ghulam Rehman Mohyuddin, Rakesh Popat, Shonali Midha, Melissa Ng, Simon J. Harrison, Aaron S. Kesselheim, Benjamin W. Teh

    Izdano 2023
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    The lucent yet opaque challenge of regulating artificial intelligence in radiology

    The lucent yet opaque challenge of regulating artificial intelligence in radiology od James Hillis, Jacob J. Visser, Edward R. Scheffer Cliff, Kelly van der Geest – Aspers, Bernardo C. Bizzo, Keith J. Dreyer, Jeremias Adams‐Prassl, Katherine P. Andriole

    Izdano 2024
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma

    Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma od Tobias Tix, Mohammad Alhomoud, Roni Shouval, Gloria Iacoboni, Edward R. Scheffer Cliff, Doris K. Hansen, Saad Z. Usmani, Gilles Salles, Miguel‐Angel Perales, David M. Cordas dos Santos, Kai Rejeski

    Izdano 2025
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Dietary interventions in cancer: a systematic review of all randomized controlled trials

    Dietary interventions in cancer: a systematic review of all randomized controlled trials od Nosakhare Paul Ilerhunmwuwa, Abul Hasan Shadali Abdul Khader, Calvin Smith, Edward R. Scheffer Cliff, Christopher M. Booth, Evevanne Hottel, Muhammad Aziz, Wade Lee‐Smith, Aaron M. Goodman, Rajshekhar Chakraborty, Ghulam Rehman Mohyuddin

    Izdano 2024
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy

    A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy od David M. Cordas dos Santos, Tobias Tix, Roni Shouval, Anat Gafter‐Gvili, Jean-Baptiste Alberge, Edward R. Scheffer Cliff, Sebastian Theurich, Michael von Bergwelt‐Baildon, Irene M. Ghobrial, Kai Rejeski, Miguel‐Angel Perales, Kai Rejeski

    Izdano 2024
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition

    Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition od Thomas E. Lew, Victor S. Lin, Edward R. Scheffer Cliff, Piers Blombery, Ella R. Thompson, Sasanka M. Handunnetti, David Westerman, Bryone J. Kuss, Constantine S. Tam, David C.S. Huang, John F. Seymour, Andrew W. Roberts, Mary Ann Anderson

    Izdano 2021
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma

    Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma od Rajshekhar Chakraborty, Heloise Cheruvalath, Anannya Patwari, Anikó Szabó, Carolina Schinke, Binod Dhakal, Suzanne Lentzsch, Anita D’Souza, Ghulam Rehman Mohyuddin, Kelley Julian, Shonali Midha, Patrick Costello, Martin Kaiser, Melissa Ng, Simon J. Harrison, Edward R. Scheffer Cliff, Meera Mohan

    Izdano 2024
    Polni tekst
    Carta
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: